Pharma & Biotech

Add to MyProactive

Algernon Pharmaceuticals begins screening patients for Phase 2...

Steve Darling

12.13 Fri 10 Jul 2020

Medexus Pharmaceuticals Inc - Medexus Pharmaceuticals Inc says joint-pain drug Triamcinolone Hexacetonide has been added to public drug plans in five Canadian provinces

Health Medexus says joint-disease drug added to public drug plans in four...

1 day, 18 hours ago

cell

Health InnoCan Pharma collaborating with Recipharm in Israel to...

1 day, 19 hours ago

Newspapers and laptop

Health NA Proactive news snapshot: OTC Markets Group, Cardiol...

2 days, 11 hours ago

LeanLife Health - LeanLife Health Inc hammers out the broad strokes of a deal with leading European energy drink maker

Health LeanLife Health hammers out the broad strokes of a deal with...

2 days, 20 hours ago

Algernon Pharmaceuticals Inc. - Algernon screens patients in Australia for Phase 2 Ifenprodil clinical study aimed at treating a type of lung disease and chronic cough

Algernon screens patients in Australia for Phase 2 Ifenprodil clinical study aimed at treating a type of lung disease and chronic cough

3 days, 13 hours ago

Bioasis Technologies Inc. - Bioasis Technologies Inc draws higher valuation from Edison Investment Research

Bioasis Technologies draws higher valuation from Edison Investment Research

1 week, 2 days ago

Revive Therapeutics - Revive Therapeutics

Revive Therapeutics returns with repurposed gout drug to fight COVID-19 and push into psychedelic medicine

1 week, 2 days ago

Revive Therapeutics -

Revive Therapeutics submits IND application to the FDA for potential coronavirus treatment Bucillamine

1 week, 4 days ago

BetterLife Pharma Inc -

BetterLife Pharma planning Phase 2 trial using nebuliser and its AP-003 drug to fight coronavirus

1 week, 4 days ago

Bioasis Technologies Inc. - Bioasis and Chiesi Group announce strategic alliance to treat lysosomal storage disorders

Bioasis Technologies and Chiesi Group announce strategic alliance to treat lysosomal storage disorders

1 week, 4 days ago

Antibe Therapeutics Inc -

Antibe Therapeutics closes $28.75 million offering ahead of planned Phase 3 trial of ATB-346

1 week, 4 days ago

Revive Therapeutics - Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move towards clinic

Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move towards clinic

1 week, 4 days ago

health

Revive Therapeutics: Initiation report

1 week, 4 days ago

Acasti Pharma Inc -

Acasti Pharma eyeing TRILOGY 2 data as it reveals phenomenon of 'triglyceride normalization' could have played part in first trial

1 week, 5 days ago

Cardiol Therapeutics -

Cardiol Therapeutics appoints financial markets expert Steven Grasso as business advisor

1 week, 5 days ago

Havn Life - Havn Life Sciences to take its magic-mushroom growing firm public this summer

Havn Life Sciences to take its magic-mushroom growing firm public this summer

2 weeks, 1 day ago

Helix BioPharma Corp. - Helix BioPharma Corp to divest its remaining shares in Polish subsidiary Helix Immuno-Oncology SA

Helix BioPharma to divest its remaining shares in Polish subsidiary Helix Immuno-Oncology

2 weeks, 1 day ago

Algernon Pharmaceuticals receives ethics approval as they begin clinical trials for Ifenprodil

Algernon Pharmaceuticals receives ethics approval as they begin clinical trials for Ifenprodil

2 weeks, 2 days ago

microscope

PreveCeutical turns focus on developing preventive and curative therapies to COVID-19

2 weeks, 2 days ago